The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Transiderm-Nitro 5milligrams/24 hours Transdermal Patch

Novartis Ireland LimitedPA0896/032/001

Main Information

Trade NameTransiderm-Nitro 5milligrams/24 hours Transdermal Patch
Active SubstancesGlyceryl trinitrate
Dosage FormTransdermal patch
Licence HolderNovartis Ireland Limited
Licence NumberPA0896/032/001

Group Information

ATC CodeC01DA Organic nitrates
C01DA02 glyceryl trinitrate


License statusAuthorised
Licence Issued11/04/1985
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back